Von Willebrand's Disease Type 2B research hub

Efficacy and Safety of BT200 (rondaptivon pegol) in Patients with Type 2B von Willebrand disease

This study is testing a new medicine called rondaptivon pegol (BT200) for adults with type 2B von Willebrand disease. Researchers want to see if the medicine can safely raise platelet levels in the blood and reduce how often patients experience bleeding episodes compared to a simple saltwater injection.